CRM) Investors Who Have a Loss Investigating a Company for Securities Fraud, Contact Us for Details Via Investing.com
NEW YORK, June 29, 2024 (GLOBE NEWSWIRE) — Leading security law firm Bleichmar Fonti & Auld LLP announces an investigation into Salesforce, Inc. (NYSE:) for possible violations of federal securities laws.
If you’re invested in Salesforce, you are You are encouraged to send your information to .
Why Is Salesforce’s Stock Falling?
On May 29, 2024, Salesforce reported its financial results for Q1 2025. For the most part, Salesforce’s reported revenue of $9.13 billion in revenue came in below the mid-range of the previously issued guidance range and the current remaining operating liability growth rate. The ”key booking metric” came under the company’s vision. Salesforce also issued Q2 2025 revenue guidance of $9.2 billion to $9.25 billion, below consensus estimates.
As a result, Salesforce’s stock price fell more than 20% at the close of trading on May 30, 2024. The BFA is investigating whether Salesforce and some of its executives made false and/or misleading statements to investors related to Salesforce’s customer acquisition environment and / or the company’s marketing capabilities.
Submit your information here: .
What Can You Do?
If you have invested in Salesforce, Inc. You may have legal options and are encouraged to submit your information to the company. All representation is on a contingency fee basis, at no cost to you. Shareholders are not responsible for any court costs or litigation expenses. The company will seek court approval for any potential fees and costs.
Find out more by visiting:
Or contact:
Ross Shikowitz
ross@bfalaw.com
212-789-3619
Why Bleichmar Fonti and Auld LLP?
Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the top 5 plaintiffs’ firms by ISS SCAS in 2023 and its attorneys were named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its most notable recent achievements, BFA received over $900 million from Tesla (NASDAQ: ), Inc.’s Board of Directors. (pending court approval), and $420 million in Teva Pharmaceutical (NYSE: ) Ind. Ltd.
For more information about the BFA and its advocates, please visit
Advocate advertising. Past results do not guarantee future results.
